Endogenous adipose-derived factors diminish coronary endothelial function via inhibition of nitric oxide synthase

Gregory A Payne1, Léna Borbouse, Ian N Bratz

  • 1Department of Cellular and Integrative Physiology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.

Microcirculation (New York, N.Y. : 1994)
|June 25, 2008
PubMed

Insights

Adipose tissue releases factors that impair blood vessel function by inhibiting nitric oxide (NO) production. This finding links obesity to vascular disease by affecting endothelial-dependent vasodilation.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Obesity Research

Background:

  • Obesity is linked to vascular disease, with adipocytokines potentially mediating this connection.
  • The precise impact of adipose-derived factors on coronary vascular function remains unclear.

Purpose of the Study:

  • To investigate the mechanisms by which endogenous adipose-derived factors influence coronary vascular endothelial function.
  • To determine if adipose tissue affects endothelial-dependent and independent vasodilation.

Main Methods:

  • Studied isolated canine coronary arteries and coronary blood flow in anesthetized dogs.
  • Exposed vessels and blood flow to adipose tissue or adipose-conditioned buffer.
  • Utilized bradykinin for endothelial-dependent vasodilation and sodium nitroprusside for endothelial-independent vasodilation.
  • Assessed nitric oxide (NO) production and oxidative stress markers.

Main Results:

  • Adipose tissue impaired endothelial-dependent vasodilation to bradykinin but not endothelial-independent vasodilation to sodium nitroprusside.
  • Adipose tissue reduced baseline and bradykinin-stimulated nitric oxide (NO) production.
  • Inhibition of NO synthase with L-NAME mimicked the effect of adipose tissue, and blocking NO synthase abolished adipose tissue's impact.
  • Oxidative stress was not the cause of impaired vasodilation.

Conclusions:

  • Adipose tissue releases factors that selectively inhibit endothelial-dependent vasodilation.
  • These factors act by suppressing nitric oxide synthase-mediated NO production.
  • This mechanism provides insight into how obesity contributes to vascular dysfunction.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...